We have located links that may give you full text access.
Anesthesia-Induced Posterior Reversible Encephalopathy Syndrome (PRES) in a Postoperative Patient.
Chest 2014 October 2
SESSION TITLE: Critical Care Student/Resident Case Report Posters ISESSION TYPE: Medical Student/Resident Case ReportPRESENTED ON: Tuesday, October 28, 2014 at 01:30 PM - 02:30 PMINTRODUCTION: Posterior Reversible Encephalopathy Syndrome (PRES) is a neurotoxic state defined by variable clinical signs and symptoms, unique radiological features, and general reversibility of the condition. Presentation may include headache, nausea, vomiting, altered mental status, seizures, and visual loss or disturbances. Neuroimaging shows characteristic transient changes, and diagnosis is typically made using MRI. Treatment of PRES should focus on the underlying cause which may include hypertension, severe infection, shock, eclampsia, immunosuppressive therapies, renal insufficiency, lupus, and therapeutic agents.CASE PRESENTATION: A 68-year-old female with known history of diverticulosis presented to the emergency department (ED) complaining of 3 days of worsening LLQ pain. Review of systems was notable for fever, chills, diarrhea, and vomiting. On physical exam, the abdomen was distended and diffusely tender with guarding. CT showed perforated sigmoid diverticulitis with local extraluminal air. The patient was brought for surgical resection of the perforated bowel. A successful Hartmann's procedure was performed under general anesthesia with minimal blood loss. Following a postoperative course complicated by ARDS and septic shock, the patient failed to regain normal mental status becoming uncooperative and combative. On POD7, head CT showed bilateral parietal-occipital white matter lucencies. Follow up MRI showed bilateral and symmetric T2 hyperintensities confined to posterior cerebral and cerebellar white matter. The symmetrical nature and location of the abnormality made it highly suspicious for PRES. The patient continued to receive supportive measures and was discharged on POD21 with minimal deficit.DISCUSSION: The cause of acute PRES is not completely understood, and proposed mechanisms attribute the condition to vasogenic edema resulting from a disruption of the blood-brain barrier and autoregulatory function. If untreated, vasogenic edema will progress to cytotoxic edema, ischemia, and infarction of brain tissues. On T2 MRI, PRES appears as bilateral hyperintensities predominantly in the white matter of the posterior cerebral hemispheres. On T1 MRI, hypointensities/isointensities appear in the same localized regions.1 CT studies are inconsistent, making MRI the favored modality.CONCLUSIONS: This case highlights the need to recognize the non-specific neurological symptoms associated with PRES especially when monitoring critically ill and intubated postoperative patients. Reversible with appropriate treatment, early recognition and diagnosis is crucial to prevent the complicating factors of prolonged PRES, specifically cytotoxic edema. Increased awareness will allow for rapid ordering of appropriate neuroimaging, and confirmation of characteristic radiological findings will prevent misdiagnosis.Reference #1: Lamy C, et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004 Apr;14(2):89-96.DISCLOSURE: The following authors have nothing to disclose: Eric Boccio, Fiore Mastroianni, Todd SlesingerNo Product/Research Disclosure Information.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app